When researchers began to develop what they hoped would be an effective COVID-19 vaccine, they already knew that H1N1 influenza—a novel virus, like COVID-19 – more severely affected patients with overweight or obesity. Patients with a body mass index of 30 or above had a higher risk of hospitalization and death from H1N1.